Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, Isabelle Ray‐Coquard et al.|The Lancet Oncology|2024Cited by 70
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelinesGiacomo Bregni, Francesco Sclafani, Tuğba Akın Telli et al.|Cancer Treatment Reviews|2019Cited by 19
Unravelling Peritoneal Carcinomatosis Using Cross-Sectional Imaging ModalitiesAna Verón Sánchez, Maria Antonietta Bali, Ilias Bennouna et al.|Diagnostics|2023Cited by 13
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancerGiacomo Bregni, Francesco Sclafani, Caroline Vandeputte et al.|Acta Oncologica|2021Cited by 11
Deep Epigastric Lymph Nodes Implication in Patients’ Recurrence Pattern After Cytoreductive Surgery in Colorectal Peritoneal MetastasesAntoine El Asmar, Gabriel Liberale, Michaël Vouche et al.|Journal of Gastrointestinal Surgery|2022Cited by 4